VETERINARY ORAL FORMULATION
CordenPharma is uniquely positioned to support Veterinary Health companies in the Contract Development and Manufacturing of their Oral Drug Product requirements - with particular expertise and a dedicated, segregated building exclusively for the manufacture of Veterinary Drug Products which have not been previously destined for clinical studies in humans. This approach guarantees we meet the most stringent compliance requirements from all Health Authorities, including ANVISA.
Our state-of-the-art manufacturing facility is designed to produce a full spectrum of products – from small volume companion animal products, to large volume (500 Kg batches) production animal products.
The facility is equipped with two independent lines. One capable of handling granulation with organic solvent and the other, high shear granulation with aqueous binder. Both lines are able to handle highly potent compounds.
CordenPharma’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs), Finished Dosage and Packaging in our network of facilities allows clients full access to integrated services resulting in a simplified supply chain, reduced risk and cost associated with technology transfers, and ultimately faster production and delivery timelines.